U.S. FDA approves Roche’s lymphoma therapyBusiness, R&D, TherapeuticsThe U.S. health regulator has approved Roche Holding AG’s therapy for treating a type of rare cancer called follicular lymphoma. Read more December 23, 2022/by Reuters Health https://www.pharmalive.com/wp-content/uploads/2022/04/ReutersRochelogo4-04-2022.webp 756 1200 Reuters Health https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png Reuters Health2022-12-23 07:05:512022-12-23 10:03:20U.S. FDA approves Roche’s lymphoma therapy
